{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:11:27Z","timestamp":1790957487875,"version":"4.1.0"},"reference-count":33,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Novo Nordisk A\/S","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether achieving a minimum of 15% weight loss early after type 2 diabetes diagnosis was associated with subsequent lower risks of developing macrovascular and microvascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Using U.K. primary care data from Clinical Practice Research Datalink Aurum linked to hospital and mortality data, we conducted a cohort study (2000\u20132024) of adults with obesity and type 2 diabetes. Individuals with \u226515% weight loss within 2 years of type 2 diabetes diagnosis were propensity score matched 1:4 to control subjects maintaining a stable weight (&amp;lt;2% weight change). Cumulative incidence rates were determined, and time to first macrovascular (myocardial infarction, stroke, angina, peripheral arterial disease) and microvascular (chronic kidney disease, retinopathy, neuropathy) events was analyzed using Cox proportional hazards regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The matched cohort included 14,496 individuals with \u226515% weight loss and 57,984 control subjects. Compared with control subjects, the weight loss group had significantly lower risk of first macrovascular (hazard ratio 0.86, 95% CI 0.81\u20130.91) and microvascular (hazard ratio 0.90, 95% CI 0.86\u20130.94) events. Individually, significantly lower risks were observed for myocardial infarction, angina, chronic kidney disease, and retinopathy. The weight loss group also demonstrated better glycemic and blood pressure levels, despite fewer medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Achieving \u226515% weight loss early in type 2 diabetes was associated with clinically meaningful lower risks for macro- and microvascular complications and better glycemic control compared with stable weight. These real-world findings support prioritizing early, substantial weight reduction as a core therapeutic strategy to improve glycemic control and prevent end-organ damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title\/>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0937","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:31:41Z","timestamp":1780947101000},"page":"1480-1489","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Achieving at Least 15% Weight Loss Within 2 Years of Type 2 Diabetes Diagnosis Is Associated With Lower Risks of Macrovascular and Microvascular Complications: A U.K. Cohort Study"],"prefix":"10.2337","volume":"49","author":[{"given":"Eva","family":"Johnsen","sequence":"first","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bengtsson","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Halasa","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Lotfi","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire P.","family":"Miller","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riia K.","family":"Sustarsic","sequence":"additional","affiliation":[{"name":"Novo Nordisk A\/S, S\u00f8borg 1 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"University of Glasgow 2 , Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026082716265626500_B1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2337\/dci25-0069","article-title":"Why early, large-scale weight loss is the future of type 2 diabetes care","volume":"49","author":"Sattar","year":"2026","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dci23-0041","article-title":"Cardiovascular and kidney risks in individuals with type 2 diabetes: contemporary understanding with greater emphasis on excess adiposity","volume":"47","author":"Sattar","year":"2024","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","article-title":"Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation","volume":"399","author":"Lingvay","year":"2022","journal-title":"Lancet"},{"key":"2026082716265626500_B4","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.2337\/dc26-S003","article-title":"3. Prevention or delay of diabetes and associated comorbidities: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B5","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.2337\/dc26-S008","article-title":"8. Obesity and weight management for the prevention and treatment of diabetes: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ijcp.12384","article-title":"The importance of weight management in type 2 diabetes mellitus","volume":"68","author":"Wilding","year":"2014","journal-title":"Int J Clin Pract"},{"key":"2026082716265626500_B8","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.7861\/clinmed.2021-0370","article-title":"Managing obesity in people with type 2 diabetes","volume":"21","author":"Grant","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"2026082716265626500_B9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"2026082716265626500_B11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","article-title":"5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study","volume":"12","author":"Lean","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B12","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"key":"2026082716265626500_B13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(15)00334-4","article-title":"Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study","volume":"3","author":"Eliasson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"2026082716265626500_B15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2337\/dc18-er06","article-title":"Erratum. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders. Diabetes Care 2016;39:808\u2013815","volume":"41","author":"Steven","year":"2018","journal-title":"Diabetes Care"},{"key":"2026082716265626500_B16","doi-asserted-by":"crossref","first-page":"e1002985","DOI":"10.1371\/journal.pmed.1002985","article-title":"Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: a registry-based cohort study","volume":"16","author":"Jans","year":"2019","journal-title":"PLoS Med"},{"key":"2026082716265626500_B17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(24)00194-3","article-title":"Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation","volume":"12","author":"Valabhji","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B18","doi-asserted-by":"crossref","first-page":"e003389","DOI":"10.1136\/bmjopen-2013-003389","article-title":"Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)","volume":"3","author":"Bhaskaran","year":"2013","journal-title":"BMJ Open"},{"key":"2026082716265626500_B19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026082716265626500_B20","unstructured":"National Institute for Health and Care Excellence (NICE)\n          . Type 2 diabetes in adults: management NICE guideline [NG28]. Accessed 20 April 2026. Available from https:\/\/www.nice.org.uk\/guidance\/ng28"},{"key":"2026082716265626500_B21","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1161\/CIR.0000000000001396","article-title":"Correction to: 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation"},{"key":"2026082716265626500_B22","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"},{"key":"2026082716265626500_B23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurheartj\/ehz388","article-title":"Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur Heart J"},{"key":"2026082716265626500_B24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","article-title":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies","volume":"377","author":"Wormser","year":"2011","journal-title":"Lancet"},{"key":"2026082716265626500_B25","doi-asserted-by":"crossref","first-page":"e13656","DOI":"10.1111\/obr.13656","article-title":"Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: a systematic review and meta-analysis","volume":"25","author":"Iqbal","year":"2024","journal-title":"Obes Rev"},{"key":"2026082716265626500_B26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-023-06048-6","article-title":"Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study","volume":"67","author":"Gregg","year":"2024","journal-title":"Diabetologia"},{"key":"2026082716265626500_B27","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00125-021-05471-x","article-title":"Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)","volume":"64","author":"Leslie","year":"2021","journal-title":"Diabetologia"},{"key":"2026082716265626500_B28","doi-asserted-by":"crossref","first-page":"100111","DOI":"10.1016\/j.lansea.2022.100111","article-title":"Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby)","volume":"9","author":"Sattar","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026082716265626500_B29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2213-8587(24)00346-2","article-title":"Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials","volume":"13","author":"Kanbour","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B30","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/dom.70350","article-title":"Clinical implications of intentional weight loss in people living with type 2 diabetes: a real-world database study","volume":"28","author":"Jain","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"2026082716265626500_B31","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"key":"2026082716265626500_B32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082716265626500_B33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40292-025-00766-1","article-title":"Intensive versus standard blood pressure control in type 2 diabetes: cardiovascular and microvascular outcomes","volume":"33","author":"Akhtar","year":"2026","journal-title":"High Blood Press Cardiovasc Prev"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1480\/881312\/dc260937.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1480\/881312\/dc260937.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:27:05Z","timestamp":1787862425000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/8\/1480\/170063\/Achieving-at-Least-15-Weight-Loss-Within-2-Years"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,8]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0937","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}